Economic news
Sanofi Says it does not intend to make an offer for horizon, leaving Amgen as sole bidder
2022.12.11 15:08
© Reuters. FILE PHOTO: Sanofi’s logo at the company’s headquarters in Paris, France, February 4, 2022. REUTERS/Benoit Tessier
(Reuters) -French health group Sanofi (NASDAQ:) said on Sunday that it no longer intends to make an offer for biotech company Horizon Therapeutics Plc (O:), leaving Amgen Inc (NASDAQ:) as the only remaining bidder.
The Wall Street Journal reported on Sunday that Amgen was in advanced talks to buy Horizon. A deal could be finalised by Monday assuming the talks with Amgen don’t fall apart, the report added.
